Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg

摘要

Background Risperidone is a benzisoxazole derivate and is effective in the treatment of schizophrenia and other psychiatric illnesses in adults and children. Although there are a few reports in the literature regarding the pharmacokinetic characteristics of risperidone, insufficient data on its pharmacokinetic properties in a Chinese population are available.